Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2002;40:251-255
Published online before print July 29, 2002, doi: 10.1161/01.HYP.0000029094.85023.01
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/3/251    most recent
01.HYP.0000029094.85023.01v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murakami, K.
Right arrow Articles by Kohno, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murakami, K.
Right arrow Articles by Kohno, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Failure
Related Collections
Right arrow Heart failure - basic studies

(Hypertension. 2002;40:251.)
© 2002 American Heart Association, Inc.


Scientific Contributions

Perindopril Effect on Uncoupling Protein and Energy Metabolism in Failing Rat Hearts

Kazushi Murakami; Katsufumi Mizushige; Takahisa Noma; Teppei Tsuji; Shoji Kimura; Masakazu Kohno

From the Second Department of Internal Medicine (K. Murakami, K. Mizushige, T.N., T.T., M.K.) and Department of Pharmacology (S.K.), Kagawa Medical University, Kagawa, Japan.

Correspondence to Katsufumi Mizushige, MD, PhD, Second Department of Internal Medicine, Kagawa Medical University, 1750-1, Miki, Kita, Kagawa 761-0793 Japan. E-mail katsumz{at}kms.ac.jp

Uncoupling proteins, inner mitochondrial membrane proton transporters, are important for regulating myocardial energy efficiency. We investigated the effects of the ACE inhibitor perindopril on cardiac performance, myocardial energy efficiency, and uncoupling protein expression in an aortic regurgitation rat model. Twenty male Sprague-Dawley rats, in which aortic regurgitation was produced, were divided into untreated and perindopril-treated (5 mg · kg-1 · d-1) rats. The treatments were initiated 3 days after operation. Ten control rats were sham-operated. Measurements of blood pressure and echocardiography were repeated before and 100 days after operation (endpoint). Left ventricular uncoupling protein-2 expression, creatine phosphate, and adenosine triphosphate were measured at endpoint. In perindopril-treated rats, systolic and diastolic blood pressure decreased after treatment (92±4/65±2 mm Hg). At endpoint, left ventricular end-diastolic dimension in untreated (10.7±0.2 mm) and treated rats (9.2±0.2 mm) was increased, and fractional shortening was reduced in untreated rats (28±1%) but did not change in treated rats (36±2%). Uncoupling protein-2 mRNA expression increased in untreated rats (3.7-fold) and was suppressed by perindopril (1.5-fold). The creatine phosphate was reduced in untreated rats (10.6±0.7 µmol/g) but not in treated rats (15.9±2.0 µmol/g). In the chronic stage of aortic regurgitation, perindopril improved cardiac performance and myocardial energy efficiency, in which the suppression of uncoupling protein-2 may play an important role.


Key Words: uncoupling proteins • heart failure • metabolism • angiotensin-converting enzyme • rats • cardiac function




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
X. Chen, K. Wang, J. Chen, J. Guo, Y. Yin, X. Cai, X. Guo, G. Wang, R. Yang, L. Zhu, et al.
In Vitro Evidence Suggests That miR-133a-mediated Regulation of Uncoupling Protein 2 (UCP2) Is an Indispensable Step in Myogenic Differentiation
J. Biol. Chem., February 20, 2009; 284(8): 5362 - 5369.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Tsutsui, S. Kinugawa, and S. Matsushima
Mitochondrial oxidative stress and dysfunction in myocardial remodelling
Cardiovasc Res, February 15, 2009; 81(3): 449 - 456.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Bodyak, D. L. Rigor, Y.-S. Chen, Y. Han, E. Bisping, W. T. Pu, and P. M. Kang
Uncoupling protein 2 modulates cell viability in adult rat cardiomyocytes
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H829 - H835.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. W. Dorn II
The Fuzzy Logic of Physiological Cardiac Hypertrophy
Hypertension, May 1, 2007; 49(5): 962 - 970.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. P. Sanders
Did they lower stress in the trial?: Or was it just wasted energy?
J. Am. Coll. Cardiol., March 15, 2005; 45(6): 858 - 859.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. A Nikolaidis, A. Sturzu, C. Stolarski, D. Elahi, Y.-T. Shen, and R. P Shannon
The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy
Cardiovasc Res, February 1, 2004; 61(2): 297 - 306.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Teshima, M. Akao, S. P. Jones, and E. Marban
Uncoupling Protein-2 Overexpression Inhibits Mitochondrial Death Pathway in Cardiomyocytes
Circ. Res., August 8, 2003; 93(3): 192 - 200.
[Abstract] [Full Text] [PDF]